The government is reportedly gearing up to impose a new contract for junior doctors after it was rejected by British Medical Association members.
News
Charity calls on NICE to reverse Opdivo rejection
Kidney Cancer UK is calling on the National Institute for Health and Care Excellence to reverse a preliminary decision to bar patients with kidney cancer from NHS access to the first immunotherapy approved for the disease.
EU expands label of Amgen’s Kyprolis
European regulators have cleared the use of Amgen’s Kyprolis in combination with just dexamethasone to treat certain adults with multiple myeloma.
Most GP practices in England now set up for online access
More than 95 percent of GP practices in England are now set up to offer online access to detailed GP records, up from just three percent at the start of the year, official figures show.
NHS finance heads fear for patient care quality
A significant portion of NHS finance directors believe that the quality of patient care will deteriorate in 2016/17 while many are questioning the likely success of financial support measures, according to findings of the latest NHS Financial Temperature Check survey.
NICE backs Ferring’s Firmagon
Men with advanced hormone-dependent prostate cancer and spinal metastases are to gain routine access to Ferring’s Firmagon on the NHS after a NICE u-turn saw the cost regulator issue final draft guidance endorsing its use.
LEO buys rights to AstraZeneca’s skin drug
LEO Pharma has entered a strategic partnership with AstraZeneca for new medicines for atopic dermatitis and psoriasis, major skin diseases with a significant unmet medical need.
NICE quality standard to boost earlier cancer diagnosis
The National Institute for Health and Care Excellence has published a new quality standard that aims to speed up cancer diagnosis and save thousands of lives every year.
AstraZeneca, Genzyme named for ABPI code breaches
AstraZeneca and Genzyme have been named and shamed in advertisements for separate breaches of the Association of the British Pharmaceutical Industry’s Code of Practice.
AbbVie’s Humira bags 10th US nod for eye disease
The FDA has approved AbbVie’s Humira for the treatment of non-infectious intermediate, posterior and panuveitis, marking its 10th green light in the country for an immune-mediated disease
Hospital diabetes audit shows room for improvement
The number of patients with hospital acquired foot ulcers has been slashed by 50 percent thanks to the launch of the diabetes inpatient audit, show figures from the Health and Social Care Information Centre.
Pharma spent £340m on healthcare partnerships in 2015
The pharmaceutical industry dished out £340.3 million last year to healthcare professionals and organisations, a new payment disclosure database has revealed.
60% response rate with Novartis’ rare blood cancer drug
A mid-stage trial assessing Novartis’ experimental rare blood cancer (midostaurin) has shown high response rates in patients with systemic mastocytosis.
Leukaemia drug shows promise in ovarian cancer
A drug approved for leukaemia has also shown promise in treating a specific type of ovarian cancer in a Cancer Research UK-funded study published in the journal Molecular Cancer Therapeutics.
BMS, PsiOxus to test new cancer combo
Bristol-Myers Squibb and England’s PsiOxus Therapeutics have announced a deal to work together on a new combination therapy targeting several different tumour types in late-stage cancer patients.
